1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Bladder Cancer Global Clinical Trials Review, H2, 2015

Bladder Cancer Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • GlobalData
  • -
  • 105 pages

Bladder Cancer Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2015" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Bladder Cancer Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bladder Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bladder Cancer 25
Subjects Recruited Over a Period of Time 34
Clinical Trials by Sponsor Type 35
Prominent Sponsors 36
Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials 37
Prominent Drugs 38
Latest Clinical Trials News on Bladder Cancer 39
Aug 10, 2015: BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma 39
Jul 13, 2015: In a pivotal study, Roche's investigational immunotherapy atezolizumab shrank tumours in people with a specific type of bladder cancer 39
Jun 01, 2015: Roche presents encouraging update on metastatic bladder cancer data for atezolizumab (MPDL3280A, anti-PDL1) 40
Jun 01, 2015: OncoGenex Announces Data from Borealis-1 Trial Showing Clinical Benefit with Apatorsen in Metastatic Bladder Cancer 41
May 20, 2015: OncoGenex To Present Phase II Study Data On Apatorsen At ASCO 2015 Annual Meeting 42
Clinical Trial Profiles 43
Clinical Trial Overview of Top Companies 43
GlaxoSmithKline Plc 43
Clinical Trial Overview of GlaxoSmithKline Plc 43
Eli Lilly and Company 45
Clinical Trial Overview of Eli Lilly and Company 45
F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47
Merck and Co., Inc. 49
Clinical Trial Overview of Merck and Co., Inc. 49
Pfizer Inc. 50
Clinical Trial Overview of Pfizer Inc. 50
Novartis AG 51
Clinical Trial Overview of Novartis AG 51
Celgene Corporation 52
Clinical Trial Overview of Celgene Corporation 52
Oncogenex Pharmaceuticals, Inc. 53
Clinical Trial Overview of Oncogenex Pharmaceuticals, Inc. 53
Bayer AG 54
Clinical Trial Overview of Bayer AG 54
AstraZeneca Plc 55
Clinical Trial Overview of AstraZeneca Plc 55
Clinical Trial Overview of Top Institutes / Government 56
National Cancer Institute 56
Clinical Trial Overview of National Cancer Institute 56
Memorial Sloan Kettering Cancer Center 63
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 63
European Organization for Research and Treatment of Cancer 65
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 65
SWOG 66
Clinical Trial Overview of SWOG 66
The University of Texas M. D. Anderson Cancer Center 68
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 68
Eastern Cooperative Oncology Group 69
Clinical Trial Overview of Eastern Cooperative Oncology Group 69
Medical Research Council 70
Clinical Trial Overview of Medical Research Council 70
University Hospitals Birmingham NHS Foundation Trust 71
Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust 71
University of Chicago 72
Clinical Trial Overview of University of Chicago 72
Aarhus University 73
Clinical Trial Overview of Aarhus University 73
Five Key Clinical Profiles 74
Appendix 102
Abbreviations 102
Definitions 102
Research Methodology 103
Secondary Research 103
About GlobalData 104
Contact Us 104
Disclaimer 104
Source 105

List of Tables
Bladder Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Bladder Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Bladder Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Bladder Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Bladder Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 28
Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 34
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 35
Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 36
Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 37
Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 38
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 43
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 45
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 47
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 49
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 50
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 51
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 52
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2015* 53
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 54
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 55
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 56
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 63
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 65
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015* 66
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015* 68
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015* 69
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2015* 70
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2015* 71
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 72
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 73

List of Figures
Bladder Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Bladder Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 34
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 35
Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 36
Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 37
Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 38
GlobalData Methodology 103

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023

Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global Bladder Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2017 - 2022)

Global Bladder Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though ...

Bladder Cancer Treatment Drugs Markets in China

Bladder Cancer Treatment Drugs Markets in China

  • $ 4000
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

China’s demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...


Download Unlimited Documents from Trusted Public Sources

Lymphoma Statistics in Germany

  • March 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

Sexually Transmitted Disease Statistics and Cancer Statistics in the Netherlands

  • March 2017
    213 pages
  • Sexually Transm...  

    Cancer  

    Smoking Statist...  

  • Netherlands  

    Europe  

View report >

Cancer Statistics in the US

  • March 2017
    19 pages
  • Cancer  

  • United States  

View report >

Cancer Statistics

2 months ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.